1. Nieder C, Adam M, Astner ST. Disease presentation and outcome in young patients (<40 years) with brain metastases from malignant melanoma. Anticancer Res. 2008;28:1325–7.
2. Raizer JJ, Hwu WJ, Panageas KS, Wilton A, Baldwin DE, Bailey E, von Althann C, Lamb LA, Alvarado G, Bilsky MH, Gutin PH. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro-Oncology. 2008;10:199–207.
3. Chiarion-Sileni V, Murr R, Pigozzo J, Sarti S, Tomassi O, Romanini A. Brain metastases from malignant melanoma. Forum (Genova). 2003;13:170–82. quiz 190.
4. Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, Larsson O, Johansson H, Ringborg U. Central nervous system metastases of cutaneous malignant melanoma--a population-based study. Acta Oncol. 1998;37:463–70.
5. Gottschalk J, Dopel SH, Schulz J, Fuchs M, Martin H. Significance of immunohistochemistry in neuro-oncology. V. Keratin as a marker for epithelial differentiation of primary and secondary intracranial and intraspinal tumors. Zentralbl Allg Pathol. 1987;133:133–45.